It is well-known that going from drug discovery to commercialisation takes, on average, 10–15 years and poses significant costs – approximately $2.6 billion when R&a...

Cell culture is fundamental to many research and industrial processes, but traditional transport methods are fraught with challenges. Cryopreservation, the most comm...

Artificial intelligence (AI) is revolutionising drug discovery, enabling scientists to identify novel therapeutic candidates in a fraction of the time it once requir...

Small molecule microarray (SMM) is a well-established method for identifying small molecule (SM) binding interactions with a diverse range of target types. It has pr...

Phage display technology has played a key role in the discovery and optimisation of antibodies for a wide range of clinical or research applications, with its greate...

The issue of sustainability has garnered increasing attention across the globe, with particular emphasis on small and medium-sized enterprises (SME). These companies...

The evolution of disease modelling has seen a paradigm shift from the traditional use of animal models to more advanced in vitro human-based systems. This has been d...

Cell and gene therapies are treatments that currently revolutionise medicine as they have the potential to cure serious and incurable diseases. In cell therapy, livi...

Gene therapy represents a groundbreaking approach in the field of medicine, aiming to treat or prevent diseases by modifying the genetic material within a patient's ...

The pharmaceutical and biopharmaceutical sectors are undergoing transformative shifts driven by geopolitical tensions and regulatory changes. Among these changes, th...